Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
EditorialEditorial

JNM Update for 2014

Dominique Delbeke
Journal of Nuclear Medicine March 2015, 56 (3) 25A;
Dominique Delbeke
JNM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Dominique Delbeke

For over 3 years, it has been my great honor to be editor-in-chief of The Journal of Nuclear Medicine. I would like to thank all the dedicated individuals who make significant contributions to JNM, including the associate editors, editorial board members, and more than 2,000 reviewers worldwide who volunteer their time. The associate editors were selected in 2012, and I have continued to delegate to them manuscripts in their fields of expertise. I would also like to thank our two newest international associate editors: Prof. Dong Soo Lee from the Seoul National University College of Medicine and Prof. Giuliano Mariani from the University of Pisa. All these efforts combined promote the main mission of JNM: to disseminate scientific information to all SNMMI members and the medical community at large to advance the field of nuclear medicine and molecular imaging. Their contributions helped make last year quite successful. JNM was again ranked the top nuclear medicine journal worldwide (according to data in the most recent Journal Citation Reports by Thomson Reuters) and earned an impact factor of 5.563.

In 2013, David Mankoff became the associate editor for continuing education articles, which include self-assessment module (SAM) credit. At their fall meeting, the SNMMI board of directors moved that all JNM SAM articles be available free of charge to the membership, starting in October 2014. This motion allows SNMMI members to comply with part II of Maintenance of Certification at no charge for the educational materials. To keep the readership informed of promising investigational molecular imaging procedures, Jonathan McConathy, as editor of the “Focus on Molecular Imaging” series, continues to select state-of-the-art topics and authors.

In 2014, JNM manuscript submissions from around the world continued at the previous year’s rate of over 1,100. The acceptance rate was stable at 29%, and the turnaround time from submission to acceptance slightly improved to less than 12 weeks—the target. Last year, JNM accepted 315 articles, including 221 original research articles (123 clinical and 98 basic science), 10 brief communications, 10 CE/SAM articles, 10 “Focus on Molecular Imaging” articles, 13 invited perspectives, 17 letters to the editor, 15 book reviews, 4 editorials, and 2 special contributions. Of these 315 articles, 226 were published last year and 89 are scheduled to appear in early 2015. In addition, in June 2014 we published a 10-article supplement on PET/MR imaging guest-edited by Johannes Czernin.

Forty-three percent of the articles accepted for publication were from Europe, 42% from North America, 12% from Asia, 2% from Australia, and 1% from South America. The clinical articles were dominated by oncologic topics (42%), followed by neurology (15%), new radiopharmaceuticals (9%), general nuclear medicine (8%), physics and instrumentation (7%), radionuclide therapy (7%), cardiology (6%), pediatrics (5%), and infection (2%). The basic science articles were dominated by new radiopharmaceuticals (29%), followed by oncology (26%), physics and instrumentation (17%), neurology (10%), radionuclide therapy (8%), cardiology (8%), general nuclear medicine (2%), and infectious diseases (1%).

In May 2014, we surveyed authors about the JNM submission and peer review processes, online-only content, open access, and how they choose where to submit their articles. We also asked them to rate us in a variety of areas. Forty-one percent of authors who submitted a manuscript between 2011 and 2013 responded to the 28-question survey, including 366 physicians and 288 scientists, as well as technologists, residents, medical students, and radiopharmacists. Most were from Europe (52%), whereas 25% were from North America, 20% from Asia, and less than 4% from South America, Africa, and Australia. Most respondents were pleased with JNM’s submission and peer review process. Of those whose articles were accepted, 57% were very satisfied with the time from acceptance to online availability, 77% were very satisfied with the copyediting, 80% were very satisfied with the reproduction of their figures, and 81% were very satisfied with the responsiveness of the production staff. Of those whose articles were rejected, 45% found the reviewers’ comments helpful, 45% found the Editor’s comments helpful, and 50% were able to publish their papers in another journal. With regard to online-only content, 43% would be pleased if we offered this platform and only 13% would not; however, JNM currently does not have a backlog, so it was recommended that we not move forward with this option. Although most respondents believed it is important that scientific papers be openly available to the public free of charge, only 50% have published in an open access journal and even fewer (16%) are willing to pay a fee to allow immediate open access to the public.

I thank everyone who took the time to fill out the survey. Your feedback is valuable in helping us adapt our services and policies. If you would like a complete copy of the results, please contact Susan Alexander at salexand{at}snmmi.org. I also thank Harvey Ziessman and Nan Knight of Newsline for keeping the readership informed of trends in nuclear medicine, regulatory issues, and molecular imaging publications in other journals. Finally, I want to acknowledge the considerable efforts of the SNMMI Department of Communications: Susan Alexander, Steve Klein, Paulette McGee, Susan Nadolny, and Mark Sumimoto. These individuals, along with Tom Ebers in the JNM Editorial Office at Vanderbilt, work relentlessly to coordinate the efforts of the entire JNM team and to keep the review and production processes timely and efficient.

  • © 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (3)
Journal of Nuclear Medicine
Vol. 56, Issue 3
March 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
JNM Update for 2014
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
JNM Update for 2014
Dominique Delbeke
Journal of Nuclear Medicine Mar 2015, 56 (3) 25A;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
JNM Update for 2014
Dominique Delbeke
Journal of Nuclear Medicine Mar 2015, 56 (3) 25A;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Clinical Implementation of 177Lu-PSMA-617 in the United States: Lessons Learned and Ongoing Challenges
  • Prostate Cancer Theranostics: Concurrent Approvals by the Food and Drug Administration of the First Diagnostic Imaging Drug Indicated to Select Patients for a Paired Radioligand Therapeutic Drug
  • Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer: We Have the Answers
Show more Editorial

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire